NEWS - Feb 24, 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Novel Oral Formulations of Buprenorphine Read more
NEWS - Feb 9, 2015 Relmada Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference Read more
NEWS - Feb 4, 2015 Relmada Therapeutics Selects MepiGel Formulations to Advance Into Clinical Studies Read more
NEWS - Jan 16, 2015 Relmada Therapeutics to Present at 11th Annual Noble Financial Capital Markets Equity Conference Read more
NEWS - Jan 13, 2015 Relmada Therapeutics Reaches Midway Point in Dose Escalation for Phase One Study of Novel NMDA Receptor Antagonist d-Methadone Read more
NEWS - Jan 6, 2015 Relmada Therapeutics to Provide Corporate Update at 2015 Biotech Showcase™ in San Francisco Read more
NEWS - Dec 22, 2014 Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone Read more
NEWS - Dec 10, 2014 Relmada Therapeutics Appoints Christine Silverstein as Director of Investor Relations Read more
